All News

CAR-X

Improving Novel Theraputics and Early-Phase Trials
5 December 2022
Improving Novel Theraputics and Early-Phase Trials
For this interview, Phacilitate’s Ryan
FDA Fast Track Caribou Biosciences’ Allogeneic Anti-CD19 CAR-T
1 December 2022
FDA Fast Track Caribou Biosciences’ Allogeneic Anti-CD19 CAR-T
Caribou Bioscience, has announced that
“Endowing Cells with Super-Physical Properties” to Better Treat Patient Populations
29 November 2022
“Endowing Cells with Super-Physical Properties” to Better Treat Patient Populations
For this interview, Phacilitate’s Ryan
Creative Mechanisms for Growing the Biomanufacturing Industry
29 November 2022
Creative Mechanisms for Growing the Biomanufacturing Industry
Jenny Ligon, Associate Director of
POPULAR NEWS ITEMS
Image
8 December 2020

UCL’s Targeted Gene Therapy Proves Promising Against Epilepsy

Image
7 December 2020

Lessons in Commercial Success

Image
5 December 2022

EMA Accepts Application for Breakthrough Treatment of Genetic Form of ALS

The New Age of Oncology Treatment and the Patient Experience
28 November 2022
The New Age of Oncology Treatment and the Patient Experience
Courtney Horvath, Global Head of
Advancing Cell and Gene Therapies in Rare Diseases: Angelman Syndrome
28 November 2022
Advancing Cell and Gene Therapies in Rare Diseases: Angelman Syndrome
Allyson Berent, The Foundation for
Inceptor Bio and Avectas Collaborate to Improve Manufacturing of CAR-T’s for Solid Tumors
13 October 2022
Inceptor Bio and Avectas Collaborate to Improve Manufacturing of CAR-T’s for Solid Tumors
Cell therapy biotechnology company Inceptor
Looking to the Future of CAR-T Cell Therapy Manufacture
22 September 2022
Looking to the Future of CAR-T Cell Therapy Manufacture
Ryan Cawood and Robert Leydon
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

UCL’s Targeted Gene Therapy Proves Promising Against Epilepsy

Image

Lessons in Commercial Success

Image

EMA Accepts Application for Breakthrough Treatment of Genetic Form of ALS